×
Newsmax TV & Webwww.newsmax.comFREE - In Google Play
VIEW
×
Newsmax TV & Webwww.newsmax.comFREE - On the App Store
VIEW
Tags: epilespy | drug | memory | loss | alzheimer

Epilepsy Drug May Reverse Memory Loss: Johns Hopkins

By    |   Wednesday, 11 March 2015 03:27 PM

A drug commonly used to treat epilepsy has shown promise in restoring brain function and reversing memory loss in early Alzheimer's disease.

The findings suggest the drug — levetiracetam — could offer a new therapeutic approach for elderly patients who are at high risk for dementia due to early-onset Alzheimer's disease, said Johns Hopkins University researchers who conducted the study.

The drug calms hyperactivity in the brain of patients with amnestic mild cognitive impairment (aMCI) — a condition in which memory impairment is greater than expected for a person's age that flags people at risk for Alzheimer's dementia.

The findings, published in the journal NeuroImage: Clinical, confirm the conclusions of an earlier Johns Hopkins study involving laboratory animals.

Lead researcher Michela Gallagher explained that over-activity in certain regions of the brain is common in people with aMCI.

"What we've shown is that very low doses of the atypical antiepileptic levetiracetam reduces this over-activity," Gallagher said, whose team assessed the drug’s effectiveness in 84 patients. "At the same time, it improves memory performance on a task that depends on the hippocampus."

Researchers found low doses of the drug improved memory performance and normalized the over-activity detected by brain scans during a memory task.

"What we want to discover now, is whether treatment over a longer time will prevent further cognitive decline and delay or stop progression to Alzheimer's dementia," Gallagher said.

The study was funded by the National Institutes of Health.

© 2022 NewsmaxHealth. All rights reserved.


Health-News
A drug used to treat epilepsy has shown promise in restoring brain function and reversing memory loss in early Alzheimer's disease.
epilespy, drug, memory, loss, alzheimer
238
2015-27-11
Wednesday, 11 March 2015 03:27 PM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
Find Your Condition
Get Newsmax Text Alerts
TOP

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved